- Home
- IVVD vs CURV Comparison
IVVD vs CURV Comparison
Compare IVVD & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVVD | CURV |
|---|---|---|
| Founded | 2020 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.6M | 253.3M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IVVD | CURV |
|---|---|---|
| Price | $0.59 | $2.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 7 |
| Target Price | ★ $10.00 | $2.17 |
| AVG Volume (30 Days) | ★ 4.1M | 152.6K |
| Earning Date | 11-09-2026 | 12-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.02 | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | $53,426,000.00 | ★ $1,000,092,000.00 |
| Revenue This Year | $12.40 | N/A |
| Revenue Next Year | $44.85 | $1.63 |
| P/E Ratio | ★ N/A | $35.17 |
| Revenue Growth | ★ 110.47 | N/A |
| 52 Week Low | $0.53 | $0.94 |
| 52 Week High | $3.07 | $2.86 |
Technical Indicators
Market Signals| Indicator | IVVD | CURV |
|---|---|---|
| Relative Strength Index (RSI) | 38.92 | 46.94 |
| Support Level | $0.53 | $2.13 |
| Resistance Level | $1.02 | $2.32 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 19.46 | 41.23 |
Price Performance
Historical ComparisonAbout IVVD Invivyd Inc.
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand in North America dedicated to offering a diverse assortment of stylish apparel, intimates, and accessories skillfully designed for curvy women. Its extensive collection features high-quality merchandise, including tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of its e-Commerce platform and stores.